Norway· NO-ID_8CE78BBF-5A06-48B1-A3D4-55FC1030790B
Fabrazyme
A agalsidase beta product containing agalsidase beta, registered in Norway by Sanofi B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Agalsidase beta is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AB04 (agalsidase beta), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Agalsidase beta · ATC A16AB04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of agalsidase beta costs, country by country.
Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Agalsidase beta · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$638.56
The record
At a glance
FEST (Norway)- Active substance
- Agalsidase Beta
- Manufacturer
- Sanofi B.V.
- Country
- Norway (NO)
- ATC code
- A16AB04
- ATC class
- Agalsidase beta
- Defined daily dose
- 5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_8CE78BBF-5A06-48B1-A3D4-55FC1030790B
- no_varenummer0169305NOK 5761.6
- gtin358468570031
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for agalsidase beta.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Agalsidase beta · interactions on record
4 records
- 3 severe
- 1 moderate
Most severe, free to view
- AmiodaroneC01BD01severe
- GentamicinJ01GB03severe
- ChloroquineP01BA01severe
- MigalastatA16AX14moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Agalsidase beta in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandFabrazymeSanofi B.V.
- CzechiaFABRAZYMESanofi B.V., Amsterdam
- SpainFABRAZYME 5 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONSanofi B.V.
- BelgiumFabrazyme 5 mgSanofi
- United KingdomFabrazyme 5mg powder for concentrate for solution for infusion vialsSanofi
- IrelandFabrazyme 5 mg powder for concentrate for solution for infusionSanofi B.V.
- PolandFabrazymeSanofi B.V.
- Japanアガルシダーゼベータ（遺伝子組換え）サノフィ
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Fabrazyme
- Liechtenstein · Fabrazyme
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/85856749-8a6e-4290-ba97-352ec38dc5d6 GET /v1/drugs/85856749-8a6e-4290-ba97-352ec38dc5d6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Agalsidase beta",
"merkevare_id": "ID_8CE78BBF-5A06-48B1-A3D4-55FC1030790B",
"name_form_strength": "Fabrazyme pulv til kons til inf væske, oppl 5 mg",
"prescription_group": "C"
}See everything about agalsidase beta.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.